Twice each month – although there has been somewhat of a hiatus - the CEA Registry Blog lists recently published cost utility studies and associated papers. 29 papers were listed this time. Here's a few in our areas of research interest:
Obach D, Deuffic-Burban S, Esmat G, et al. Effectiveness and cost-effectiveness of immediate vs. delayed treatment of HCV-infected patients in a country with limited resources: the case of Egypt. Clin Infect Dis. 2014 Feb 7. [Epub ahead of print] PubMed PMID: 24510934.
Gulliford MC, Bhattarai N, Charlton J, et al. Cost-effectiveness of a universal strategy of brief dietary intervention for primary prevention in primary care: population-based cohort study and Markov model. Cost Eff Resour Alloc. 2014 Feb 2;12(1):4. PubMed PMID: 24485221.
van Haalen HG, Pompen M, Bergenheim K, et al. Cost effectiveness of adding dapagliflozin to insulin for the treatment of type 2 diabetes mellitus in the Netherlands. Clin Drug Investig. 2014 Feb;34(2):135-46. PubMed PMID: 24243529.
